KLHL6 protein drives colorectal cancer liver spread via MBD2 degradation
A study in the Journal of Experimental & Clinical Cancer Research identifies KLHL6 as a driver of colorectal cancer liver ...
A study in the Journal of Experimental & Clinical Cancer Research identifies KLHL6 as a driver of colorectal cancer liver ...
A review examines how the ubiquitin–proteasome system and autophagy coordinate to eliminate damaged cellular components and prevent disease.
A new study reveals that knocking down the protein Smurf1 promotes ferroptosis in acute liver failure by stabilizing Ulk1 and ...
Researchers have engineered a cell-penetrating TRIM21-based protein degrader that targets all three PIM kinase isoforms to induce apoptosis in breast ...
A review maps the neddylation pathway, its non-Cullin substrates and small-molecule inhibitors, including two NAE inhibitors that have entered clinical ...
A new review argues that the ubiquitin-proteasome system degrades P-glycoprotein at the blood-brain barrier, impairing amyloid-beta clearance and offering new ...
Researchers at Lund University have shown that pancreatic cancer cells engineered to survive detachment consistently switch on autophagy and ubiquitin ...
A new review in Cancer Cell International maps how the deubiquitinase USP7 acts as both tumor promoter and suppressor depending ...
New cryo-EM structures reveal how the HIV-1 protein Vpr reshapes the human CRL4(VprBP) E3 ligase to degrade host substrates of ...
New research reveals that the ubiquitin-editing enzyme A20 promotes the degradation of the pro-tumor protein osteopontin in hepatocellular carcinoma, offering ...
Researchers report that loss of the tumor suppressor LZTR1 stabilizes mitochondrial transcription factor A, reprogramming liver cancer cells toward complex ...
A new review argues that Huntington's disease is driven by widespread disruptions of interconnected protein networks, pointing to hub proteins ...
New research shows that female mice lacking the protein quality-control gene Herc3 suffer faster retinal thinning, greater inflammatory activation, and ...
In the evolving landscape of cancer immunotherapy, the quest for novel immune checkpoint targets has never been more urgent. Conventional ...
In a remarkable stride forward in cancer therapeutics, researchers have unveiled a groundbreaking strategy to target and degrade YAP, a ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.